by brant bullard | Mar 29, 2015 | News
The use of pharmacogenomics as a tool for medication management and metabolic validation can be extremely valuable for Hospice caregivers and medical directors.
Metabolic Validation has specific medical necessity guidelines for Hospice utilization that are very different from Home Health, Physician Clinics and other medical settings.
Unfortunately, this tool is currently being promoted in ways that are not appropriate and can be financially and legally detrimental to a Hospice company. Things such as paying a physician for referral via a survey or registry for patient that could never meet the criteria that the OIG for CMS has warranted against; and billing for every panel or gene that is not appropriate for Hospice patients.
(more…)
by brant bullard | Mar 29, 2015 | News
As a healthcare professional, are you aware of the pharmacogenomic information on FDA-approved drug labels?
Pharmacogenomic information can appear in different sections of the labeling depending on the actions. Drug labeling may contain information that describes risk for adverse events, drug exposure and clinical response variability along with many other things.
The FDA has a number of drugs with pharmacogenomic labeling. Below are a few that are prevalent in elderly patients.
(more…)
by brant bullard | Mar 23, 2015 | News
According to the CDC, each year, millions of adults aged 65 and older fall.
Falls in older adults can cause moderate to severe injuries, such as hip fractures and head traumas, and can increase the risk of early death. Fortunately, falls are a public health problem that is largely preventable.
In 2013, 2.5 million non-fatal falls amoung older adults were treated in emergency rooms and more than 734,000 of those patients were hospitalized costing an estimated $34 billion.
(more…)
by brant bullard | Mar 16, 2015 | News
Sterling House of Stillwater will host an educational meeting to discuss personalized medicine on Tuesday, March 17th, 6-7 p.m. The public is invited. Guest speaker for the event is Clay Bullard, president of Edmond-based PGx Medical.
(more…)
by brant bullard | Feb 10, 2015 | News
Oklahoma based PGx Medical expands to Houston, Texas.
Sarah Corbin and Jennifer Dvorak, PGx Medical Consultants
In October 2014, PGx Medical expanded their business to Houston, TX. Sarah Corbin and Jennifer Dvorak will handle the Texas region for PGx. PGx Medical is currently partnered with clients across the country, but recently decided to expand their footprint to the Texas area.
“Pharmacogenomics isn’t new. In fact, it has been around for decades,” said Clay Bullard, President of PGx Medical.
PGx Medical works with clinics, pharmacists and LTC facilities across the country. Their team works alongside healthcare professionals to determine how best to incorporate and implement Metabolic Validation via pharmacogenomics into their patient care.
“I’m excited about Jennifer and Sarah coming on-board,” said Bullard. “They have years of experience and are very knowledgeable on our Metabolic Validation tool. They are a great addition to our team.”
For more information contact:
PGx Medical
Individualized Care – Personalized Medicine
info@pgxmed.com
405-509-5112
by brant bullard | Jan 14, 2015 | News
“In the next 5-10 years, pharmacogenomics will revolutionize medicine and the way in which drugs are developed” – Global Business Insight
By identifying differences between patients’ genetic makeup and the effect this has on drug response, pharmacogenomics has the potential to reduce medical costs, improve drug development and therapy and cause a shift from treatment to prevention.
It is not surprising then, “that many leading industry figures believe pharmacogenomics will revolutionize the face of pharmaceutical drug development and, consequently, clinical practice”.
Pharmacogenomics and Drug Therapy:
Selection of appropriate drug and dose for the individual patient in order to:
- Achieve optimal therapeutic response
- Avoid therapeutic failure
- Minimize side effects and toxicity
The value of the metabolic validation tool, via pharmacogenomic testing, is to predict and select right drug, right dose for the right person. Making patient care more effective and improving quality of life.
For more information on pharmacogenomics, contact:
PGx Medical
Individualized Care – Personalized Medicine
405-509-5112
info@pgxmed.com
Source:
oecd.org
AAPS.org
(more…)
